NVO
Novo Nordisk A/S
NVO has slightly lower modeled downside risk, despite its lower overall score.
PARK
Park Dental Partners, Inc. Common Stock
PARK has the edge over NVO overall, supported by stronger modeled upside.
NVO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Healthy |
NVO's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
PARK Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Under pressure | |
| Strong |
PARK's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are under pressure.
NVO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 10x | $40.65 | — |
| Cheap | 14x | $53.56 | +32% |
| Fair | 27x | $103 | +154% |
| Expensive | 39x | $152 | +273% |
Historical ranges are pointers, not guarantees.
NVO's PE is 10x, but its earnings don't support one, so it isn't a reliable read right now.
PARK PE Valuation
PARK has no meaningful PE right now: it lost money over the past year.
NVO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Stable | |
| Growth | |
| Weakening | |
| Limited | |
| Low |
Analysts expect NVO's revenue to grow, but its profitability to weaken. However, they disagree widely on these estimates.
PARK Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
PARK has the edge over NVO on the outlook, with more favorable earnings and profitability expectations.
NVO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $3.89 | +4.9% |
| Q1 2026 | $4.07 | +17% |
| Q4 2025 | $3.42 | +1.8% |
| Q3 2025 | $3.47 | +10% |
| Q2 2025 | $3.71 | +24% |
| Q1 2025 | $3.49 | +18% |
| Q4 2024 | $3.36 | +21% |
| Q3 2024 | $3.15 | +27% |
NVO has the edge over PARK on earnings quality, reporting a profit while its opponent remains loss making.
PARK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.42 | — |
| Q3 2026 | -$0.95 | -177% |
| Q2 2026 | -$0.91 | -194% |
| Q1 2026 | -$0.52 | -133% |
| Q4 2025 | -$0.06 | -102% |
PARK has swung to a loss: it lost $0.95 per share over the past year, after a profit the year before.
NVO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $11.7B | +2.1% |
| Q1 2026 | $14.4B | +24% |
| Q4 2025 | $11.8B | -7.6% |
| Q3 2025 | $11.1B | +5.1% |
| Q2 2025 | $11.4B | +13% |
| Q1 2025 | $11.6B | +19% |
| Q4 2024 | $12.7B | +30% |
| Q3 2024 | $10.6B | +21% |
NVO's revenue is growing: $11.7B last quarter, up 2.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 34% | -9 points |
| Q1 2026 | 62% | +12 points |
| Q4 2025 | 40% | -2.8 points |
| Q3 2025 | 32% | -16 points |
| Q2 2025 | 44% | +5.4 points |
| Q1 2025 | 50% | +1 points |
| Q4 2024 | 43% | +2.2 points |
| Q3 2024 | 47% | +1.6 points |
NVO has the edge over PARK on profitability, with a higher operating margin.
PARK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $64.9M | +6% |
| Q2 2026 | $66.2M | +8.5% |
| Q1 2026 | $62.7M | +2.7% |
| Q4 2025 | $61.2M | +7.5% |
| Q3 2025 | $61.3M | +11% |
| Q2 2025 | $61M | +3.8% |
| Q1 2025 | $61M | +3.8% |
PARK's revenue has grown year over year every quarter since early 2025: $65M last quarter, up 6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -0.2% | -3.1 points |
| Q2 2026 | 1.9% | -3.6 points |
| Q1 2026 | -3% | -8.5 points |
| Q4 2025 | -13% | +15 points |
| Q3 2025 | 2.9% | +0.6 points |
| Q2 2025 | 5.5% | +0.3 points |
| Q1 2025 | 5.5% | +0.3 points |
| Q4 2024 | -28% | N/A |
PARK's operating margin was −0.2% last quarter, down 3.1 points from the same quarter a year ago.
NVO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $6.3B | +73% |
| Q1 2026 | $1.8B | +20% |
| Q4 2025 | -$5.4B | -$4.7B |
| Q3 2025 | $4.6B | -2.1% |
| Q2 2025 | $3.6B | -34% |
| Q1 2025 | $1.5B | +89% |
| Q4 2024 | -$632.6M | +$390.5M |
| Q3 2024 | $4.7B | +3.3% |
NVO has the edge over PARK on cash flow, with more consistent year-over-year improvement.
PARK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$569K | -110% |
| Q2 2026 | $2.2M | +26% |
| Q1 2026 | $2.7M | -21% |
| Q4 2025 | -$491K | -123% |
| Q3 2025 | $5.6M | -5.6% |
| Q2 2025 | $1.8M | +53% |
| Q1 2025 | $3.4M | +196% |
PARK usually generates cash, though not every quarter: the latest was −$569,000, but it generated $4M over the past year.
NVO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -12.9M shares |
| 1 year | -0.2% | -11M shares |
| 3 years | -1.5% | -66.8M shares |
| 5 years | -3.8% | -177M shares |
| Available history | -6.5% | -311M shares |
NVO has the edge over PARK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $520M |
| Q1 2026 | $356.7M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $206.3M |
| Q4 2024 | $1.1B |
| Q3 2024 | $357.4M |
NVO spent $877M buying back its own shares over the past year, down 48% from the year before.
PARK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2% | +126K shares |
| 1 year | +55% | +2.3M shares |
PARK has 6M diluted shares, up 55% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | $308,000 |
| Q2 2025 | $242,000 |
| Q1 2025 | $154,000 |
| Q4 2024 | — |
| Q3 2024 | $154,000 |
| Q2 2024 | — |
| Q1 2024 | — |
NVO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.7x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.4x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
| Q3 2024 | -0.0x | Very low |
NVO's net debt is less than a year of its operating earnings (EBITDA).
PARK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -27.0x | Net Cash |
| Q1 2026 | -2.8x | Net Cash |
| Q4 2025 | -2,580.6x | Net Cash |
| Q3 2025 | 2.6x | Moderate |
| Q2 2025 | 3.1x | Elevated |
| Q1 2025 | 3.2x | Elevated |
PARK has the edge over NVO on leverage, with a lower net debt burden relative to earnings.
NVO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 27.0 | Neutral |
NVO's weekly RSI is 43 (neutral) and its Stochastic is 27 (neutral).
PARK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.6 | Neutral |
| Stochastic | 32.0 | Neutral |
PARK's weekly RSI is 58 (neutral) and its Stochastic is 32 (neutral).
NVO PE vs Healthcare Sector
| Metric | NVO | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 26x | 60% below |
| PE % | 6 | 29 | 23 pts below |
NVO is trading at 10x earnings, a 60% discount to the Healthcare sector's median of 26x, though its earnings don't support one.
PARK PE vs Healthcare Sector
PARK has no meaningful PE right now: it lost money over the past year.
NVO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $39.2 | 3.7% above |
| 20 week MA | $43.9 | 7.4% below |
| 50 week MA | $45.3 | 10% below |
| 100 week MA | $56.3 | 28% below |
| 200 week MA | $80.7 | 50% below |
PARK has stronger trend alignment. NVO is above 1 of 5 weekly averages versus PARK above 3 of 3.
PARK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $20.1 | 5.3% above |
| 20 week MA | $20.3 | 4.4% above |
| 50 week MA | $18.5 | 15% above |
PARK is in an uptrend: it's above all three of its weekly moving averages, and 15% above its 50-week average.
NVO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $29.1 | $34.7 | +19% |
| 2021 | $34.7 | $54.2 | +56% |
| 2022 | $54.2 | $67.0 | +24% |
| 2023 | $67.0 | $103.5 | +54% |
| 2024 | $103.5 | $87.4 | -16% |
| 2025 | $87.4 | $52.4 | -40% |
| 2026 YTD | $52.4 | $40.7 | -22% |
NVO has finished higher in four of the last six years, two of them by more than 50%. It's down 22% so far in 2026.
PARK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $13.3 | $14.7 | +10% |
| 2026 YTD | $14.7 | $21.2 | +44% |
PARK has the edge over NVO on returns for 2026, with the stronger performance.